The AI jobs crunch, medical stocks and AstraZeneca: Companies and Markets Show

Investors Chronicle by Investors' Chronicle

M&A activity remains rampant, and this week we start with a tie-up that would rank among the biggest deals of all time: AstraZeneca and US rival Bristol Myers Squibb. Julian Hofmann discusses the merits of the mooted $40...View more